Pending Appeals Court Case Could Shift FDA’s Guidance Policy, Attorneys Say

Drugmakers dissatisfied with the FDA’s use of guidances as a form of policymaking could find relief with a case pending appeal in the U.S. Court of Appeals for the Eleventh Circuit, industry attorneys tell DID.
Drug Industry Daily